These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29109519)

  • 1. Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis.
    Wang N; Zheng Y; Gu J; Cai Y; Wang S; Zhang F; Chen J; Situ H; Lin Y; Wang Z
    Sci Rep; 2017 Nov; 7(1):14513. PubMed ID: 29109519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baohuoside i suppresses breast cancer metastasis by downregulating the tumor-associated macrophages/C-X-C motif chemokine ligand 1 pathway.
    Wang S; Wang N; Huang X; Yang B; Zheng Y; Zhang J; Wang X; Lin Y; Wang Z
    Phytomedicine; 2020 Nov; 78():153331. PubMed ID: 32911383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XIAOPI formula inhibits the pre-metastatic niche formation in breast cancer via suppressing TAMs/CXCL1 signaling.
    Zheng Y; Wang N; Wang S; Yang B; Situ H; Zhong L; Lin Y; Wang Z
    Cell Commun Signal; 2020 Mar; 18(1):48. PubMed ID: 32213179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XIAOPI formula promotes breast cancer chemosensitivity via inhibiting CXCL1/HMGB1-mediated autophagy.
    Wang N; Yang B; Muhetaer G; Wang S; Zheng Y; Lu J; Li M; Zhang F; Situ H; Lin Y; Wang Z
    Biomed Pharmacother; 2019 Dec; 120():109519. PubMed ID: 31629951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling.
    Wang N; Liu W; Zheng Y; Wang S; Yang B; Li M; Song J; Zhang F; Zhang X; Wang Q; Wang Z
    Cell Death Dis; 2018 Aug; 9(9):880. PubMed ID: 30158589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aiduqing formula suppresses breast cancer metastasis via inhibiting CXCL1-mediated autophagy.
    Yang B; Peng F; Zhang Y; Wang X; Wang S; Zheng Y; Zhang J; Zeng Y; Wang N; Peng C; Wang Z
    Phytomedicine; 2021 Sep; 90():153628. PubMed ID: 34247114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of action of Fangji Huangqi Decoction on epithelial-mesenchymal transition in breast cancer using high-throughput next-generation sequencing and network pharmacology.
    Guo Q; Pei XH; Chu AJ; Guo YB; Fan YY; Wang CH; Zhang SJ; Sun SQ; Liu YF; Wang X
    J Ethnopharmacol; 2022 Feb; 284():114793. PubMed ID: 34728317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGRN
    Yue S; Ye X; Zhou T; Gan D; Qian H; Fang W; Yao M; Zhang D; Shi H; Chen T
    Life Sci; 2021 Jan; 264():118687. PubMed ID: 33181174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fu-Zheng-Yi-Liu Formula inhibits the stem cells and metastasis of prostate cancer via tumor-associated macrophages/C-C motif chemokine ligand 5 pathway in tumor microenvironment.
    Chen C; Huang R; Wang N; Zheng Y; Zhou J; Yang B; Wang X; Zhang J; Pan B; Chen Z; Wang S; Wang Z; Xiang S
    Chin J Nat Med; 2024 Jun; 22(6):501-514. PubMed ID: 38906598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
    Li J; Wang S; Wang N; Zheng Y; Yang B; Wang X; Zhang J; Pan B; Wang Z
    Cell Commun Signal; 2021 Aug; 19(1):89. PubMed ID: 34461944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate).
    Alam F; Al-Hilal TA; Park J; Choi JU; Mahmud F; Jeong JH; Kim IS; Kim SY; Hwang SR; Byun Y
    Biomaterials; 2016 Apr; 86():56-67. PubMed ID: 26890038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines.
    Gonçalves Ndo N; Colombo J; Lopes JR; Gelaleti GB; Moschetta MG; Sonehara NM; Hellmén E; Zanon Cde F; Oliani SM; Zuccari DA
    PLoS One; 2016; 11(3):e0150407. PubMed ID: 26934679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2.
    Pei S; Yang X; Wang H; Zhang H; Zhou B; Zhang D; Lin D
    BMC Cancer; 2015 Dec; 15():965. PubMed ID: 26674531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
    Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
    Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
    Qin G; Xu F; Qin T; Zheng Q; Shi D; Xia W; Tian Y; Tang Y; Wang J; Xiao X; Deng W; Wang S
    Oncotarget; 2015 Dec; 6(39):41794-808. PubMed ID: 26540629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin.
    Nie G; Cao X; Mao Y; Lv Z; Lv M; Wang Y; Wang H; Liu C
    Int Immunopharmacol; 2021 Jun; 95():107153. PubMed ID: 33677254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung.
    Park CY; Son JY; Jin CH; Nam JS; Kim DK; Sheen YY
    Eur J Cancer; 2011 Nov; 47(17):2642-53. PubMed ID: 21852112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
    Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
    Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.